Erschienen in:
02.04.2020 | Brief Communication
Informing MS patients on treatment options: a consensus on the process of consent taking
verfasst von:
C. Tortorella, C. Solaro, P. Annovazzi, L. Boffa, M. C. Buscarinu, F. Buttari, M. Calabrese, P. Cavalla, E. Cocco, C. Cordioli, G. De Luca, M. Di Filippo, R. Fantozzi, D. Ferraro, A. Gajofatto, A. Gallo, R. Lanzillo, A. Laroni, S. Lo Fermo, S. Malucchi, G. T. Maniscalco, M. Moccia, V. Nociti, D. Paolicelli, I. Pesci, L. Prosperini, P. Ragonese, V. Tomassini, V. L. A. Torri Clerici, M. Rodegher, M. Gherardi, C. Gasperini, on behalf of the RIReMS Group
Erschienen in:
Neurological Sciences
|
Ausgabe 8/2020
Einloggen, um Zugang zu erhalten
Abstract
In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient’s empowerment in the decision-making process.
Aims
The aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice.
Results
The new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the supervision of a medico-legal advisor, received the aegis of Italian Neurological Society (SIN) and constitutes a step toward a standardized decision process around DMTs in MS.